author-photo

Stefano Petruzzelli

Chiesi Farmaceutici S.p.A.

73

Papers

990

Citations

Citation Trend

Filter By

Papers (50) Sort By

Journal Conference Others

Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.

2021 Chest
Show All
- Source
- Cite
- Save
Citations (0)
Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.

2020 Respiratory Research
Show All
- Source
- Cite
- Save
Citations (13)
Étude TRIGGER : efficacité et tolérance d’une triple association à dose fixe CSI/LABA/LAMA versus CSI/LABA et CSI/LABA + LAMA chez des asthmatiques non contrôlés

2020 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Analyse combinée des études TRIMARAN et TRIGGER : réduction des exacerbations sévères sous triple association à dose fixe en particules extrafines DPB/FF/BG versus DPB/FF dans les asthmes non contrôlés

2020 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Reducing the Rate of Severe Asthma Exacerbations Using Single-Inhaler Extrafine BDP/FF/GB Combination Compared to BDP/FF in Patients with Uncontrolled Asthma: Pooled Results from the TRIMARAN and TRIGGER Studies

2019
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA + LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study

2019
Show All
- Source
- Cite
- Save
Citations (1)
Single Inhaler Extrafine Triple Therapy Improves Clinical Outcomes in Gold B COPD Patients: Post-Hoc Analysis of the TRIBUTE study

2019
Show All
- Source
- Cite
- Save
Citations (0)
Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: Results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies

2019 Pneumologie
Show All
- Source
- Cite
- Save
Citations (0)
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

2019 International Journal of Chronic Obstructive Pulmonary Disease
Show All
- Source
- Cite
- Save
Citations (9)
Effect of high extrafine strength (HS) ICS-containing triple therapy on exacerbations in patients with severe asthma and persistent airflow limitation: Post-hoc analysis of the TRIGGER study

2019 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (1)